Estrous cyclicity and behavioral sensitization in female rats following repeated intravenous cocaine administration

Pharmacology Biochemistry and Behavior

Volumn 64, Issue 3, 1999, Pages 605-610

  Booze, Rosemarie M ^a,e   Wood, Marcie L ^e   Welch, Marian A ^c   Berry, Stepheny ^a   Mactutus, Charles F ^b,c,d,e  

^a Lexington Veterans Affairs Health Care System   (United States)

^b Division of Pharmacy Practice and Science   (United States)

^c Tobacco and Health Research Institute   (United States)

^d Department of Psychology ^*  (United States)

^e UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Body weight; Cocaine; Estrous cyclicity; Intravenous administration; Rats; Sensitization; Tolerance

Indexed keywords

COCAINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DRUG ABUSE; DRUG TOLERANCE; ESTRUS CYCLE; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; LOCOMOTION; NONHUMAN; PRIORITY JOURNAL; RAT; SENSITIZATION;

ANIMALS; BEHAVIOR, ANIMAL; COCAINE; DOPAMINE UPTAKE INHIBITORS; ESTRUS; FEMALE; INJECTIONS, INTRAVENOUS; MOTOR ACTIVITY; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA;

EID: 0032867012     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(99)00154-9     Document Type: Article

References (35)

1. Adams W.J., Yeh S.Y., Woods L.A., Mitchell C.L. Drug-test interaction as a factor in the development of tolerance to the analgesic effect of morphine. J. Pharmacol. Exp. Ther. 168:1969;251-257.
2. Benmansour S., Tejani-Butt S.M., Hauptmann M., Brunswick D.J. Lack of effect of high-dose cocaine on monoamine uptake sites in rat brain measured by quantitative autoradiography. Psychopharmacology (Berlin). 106:1992;459-462.
3. Booze R.M., Lehner A.F., Wallace D.R., Welch M.A., Mactutus C.F. Dose-response cocaine pharmacokinetics and metabolite profile following intravenous administration and arterial sampling in unanesthetized freely moving male rats. Neurotoxicol. Teratol. 19:1997;7-15.
4. Cerruti C., Pilotte N.S., Uhl G., Kuhar M.J. Reduction in dopamine transporter mRNA after cessation of repeated cocaine administration. Mol. Brain. Res. 22:1994;132-138.
5. Cohen J. Statistical power analysis for the behavioral sciences. 1988;Lawrence Erlbaum, Hillsdale, NJ.
6. Collins L.M., Meyer J.S. Distribution of cocaine and metabolites in the pregnant rat and fetus using a chronic subcutaneous injection model. Neurotoxicol. Teratol. 19:1997;249-250.
7. Disshon K.A., Boja J.W., Dluzen D.E. Inhibition of striatal dopamine transporter activity by 17β-estradiol. Eur. J. Pharmacol. 345:1998;207-211.
8. Downs A.W., Eddy N.B. The effect of repeated doses of cocaine on the rat. J. Pharmacol. Exp. Ther. 46:1932;199-200.
9. Evans S.M., Cone E.J., Henningfield J.E. Arterial and venous cocaine plasma concentration in humans. Relationship to route of administration, cardiovascular effects and subjective effects J. Pharmacol. Exp. Ther. 279:1996;1345-1356.
10. Gebhart G.F., Sherman A.D., Mitchell C.L. The influence of learning on morphine analgesia and tolerance development in rats tested on the hot plate. Psychopharmacologia. 22:1971;295-304.
11. Glick S.D., Hinds P.A. Sex differences in sensitization to cocaine-induced rotation. Eur. J. Pharmacol. 99:1984;119-121.
12. Griffin M.L., Weiss R.D., Mirin S.M., Lange U. A comparison of male and female cocaine abusers. Arch. Gen. Psychiatry. 46:1989;122-126.
13. Kalivas P.W., Duffy P., DuMars L.A., Skinner C. Behavioral and neurochemical effects of acute and daily cocaine administration in rats. J. Pharmacol. Exp. Ther. 245:1988;485-492.
14. Kalivas P.W., Stewart J. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res. Rev. 16:1991;223-244.
15. Kalivas P.W., Weber B. Amphetamine injection into the ventral mesencephalon sensitizes rats to peripheral amphetamine and cocaine. J. Pharmacol. Exp. Ther. 245:1988;1095-1102.
16. Kaufmann R.A., Savoy-Moore R.T., Subramanian M.G., Moghissi K.S. Cocaine inhibits mating-induced, but not human chorionic gonadotropin-stimulated, ovulation in the rabbit. Biol. Reprod. 46:1992;641-647.
17. King T.S., Canez M.S., Gaskill S., Javors M.A., Schenken R.S. Chronic cocaine disruption of estrous cyclicity in the rat. Dose-dependent effects J. Pharmacol. Exp. Ther. 264:1993;29-34.
18. King T.S., Schenken R.S., Kang I.S., Javors M.A., Riehl R.M. Cocaine disrupts estrous cyclicity and alters the reproductive neuroendocrine axis in the rat. Neuroendocrinology. 51:1990;15-22.
19. Kosten T.A., Gawin F.H., Kosten T.R., Rounsaville B.J. Gender differences in cocaine use and treatment response. J. Subst. Abuse Treat. 10:1993;63-66.
20. Leshner, A. I.: Filling the gender gap in drug abuse research. NIDA Notes Jan/Feb: 1995.
21. Letchworth S.R., Daunais J.B., Hedgecock A.A., Porrino L.J. Effects of chronic cocaine administration on dopamine transporter mRNA and protein in the rat. Brain Res. 750:1997;214-222.
22. Mactutus C.F., Herman A.S., Booze R.M. Chronic intravenous model for studies of drug (ab)use in the pregnant and/or group-housed rat. An initial study with cocaine Neurotoxicol. Teratol. 16:1994;183-191.
23. Orona R.A., Mayfield R.D., Cline E.J., Zahniser N.R. Repeated intravenous cocaine administration to rats produces behavioral sensitization without changing brain cocaine levels. Neurosci. Lett. 167:1994;121-124.
24. Pan H.-T., Menacherry S., Justice J.B. Jr. Differences in the pharmacokinetics of cocaine in naïve and cocaine-experienced rats. J. Neurochem. 56:1991;1299-1306.
25. Pilotte N.S., Sharpe L.G., Kuhar M.J. Withdrawal of repeated intravenous infusions of cocaine persistently reduces binding to dopamine transporters in the nucleus accumbens of Lewis rats. J. Pharmacol. Exp. Ther. 269:1994;963-969.
26. Post R.M., Contel N.R. Human and animal studies of cocaine. Implications for development of behavioral pathology Creese I. Stimulants. Neurochemical, behavioral and clinical perspectives:1983;169-203 Raven Press, New York.
27. Potter, D. A.; Moreno, A.; Luther, M. F.; Eddy, C. A.; Siler-Khodr, T. M.; King, T. S.; Schenken, R. S.: Effects of follicular-phase cocaine administration on menstrual and ovarian cyclicity in rhesus monkeys. Am. J. Obstet. Gynecol. 178:118-125: 1998.
28. Roberts D.C.S., Bennett S.A.L., Vickers G.J. The estrous cycle affects cocaine self-administration on a progressive ratio schedule in rats. Psychopharmacology (Berlin). 98:1989;408-411.
29. Selye H. Protection by estradiol against cocaine, coniine, ethylmorphine, LSD and strychnine. Horm. Behav. 2:1971;337-341.
30. 3H]mazindol-labeling of dopamine transporter in rat nucleus accumbens. Eur. J. Pharmacol. 203:1991;114-144.
31. Siegel S. Evidence from rats that morphine tolerance is a learned response. J. Comp. Physiol. Psychol. 89:1975;498-506.
32. Siegel S. Morphine analgesic tolerance. Its situation specificity supports a Palovian conditioning model Science. 193:1976;323-325.
33. Wallace D.R., Mactutus C.F., Booze R.M. Repeated intravenous cocaine administration. Locomotor activity and D2/D3 receptors Synapse. 23:1996;152-163.
34. Wise, R. A.: Neural mechanisms of the reinforcing action of cocaine. In: Pharmacology, effects and treatment of abuse. National Institute on Drug Abuse Research Monograph No. 50: 1984:153-161.
35. Zahniser N.R., Peris J. Neurochemical mechanisms of cocaine-induced sensitization. Lakoski J.M., Galloway M.P., White F.J. Cocaine. Pharmacology, physiology, and clinical strategies:1992;229-260 CRC Press, Boca Raton, FL.